Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome

Published:2018-09-20 Issue:2 Volume:19 Page:129-135
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Frommeyer Gerrit,Weller Jan,Ellermann Christian,Leitz Patrick,Kochhäuser Simon,Lange Philipp S.,Dechering Dirk G.,Eckardt Lars

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1007/s12012-018-9482-y.pdf

Reference20 articles.

1. El Chemaly, A., Magaud, C., Patri, S., Jayle, C., Guinamard, R., & Bois, P. (2007). The heart rate-lowering agent ivabradine inhibits the pacemaker current I(f) in human atrial myocytes. Journal of Cardiovascular Electrophysiology, 18, 1190–1196.

2. Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G., Coats, A. J., et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37, 2129–2200.

3. Melgari, D., Brack, K. E., Zhang, C., Zhang, Y., El Harchi, A., Mitcheson, J. S., et al. (2015). hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine. Journal of the American Heart Association, 4(4), e001813.

4. Lees-Miller, J. P., Guo, J., Wang, Y., Perissinotti, L. L., Noskov, S. Y., & Duff, H. J. (2015). Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4. Journal of Molecular and Cellular Cardiology, 85, 71–78.

5. Frommeyer, G., Weller, J., Ellermann, C., Bogeholz, N., Leitz, P., Dechering, D. G., et al. (2017). Ivabradine reduces digitalis-induced ventricular arrhythmias. Basic & Clinical Pharmacology & Toxicology, 121, 526–530.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiarrhythmic agents and torsades de pointes;Torsades de Pointes;2022

2. Pharmacokinetics, Mechanism of Action, and Adverse Effects of the Main Drugs Used to Treat Heart Failure: A Practical Overview for the Clinical Cardiologist;ABC Heart Fail Cardiomyop;2022

3. Torsadogenic Potential of HCN Channel Blocker Ivabradine Assessed in the Rabbit Proarrhythmia Model;Biological and Pharmaceutical Bulletin;2021-11-01

4. Effect of Ivabradine on Cardiac Ventricular Arrhythmias: Friend or Foe?;Journal of Clinical Medicine;2021-10-15

5. Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat;Scientific Reports;2020-09-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3